泰利克斯制药

最新新闻

• H.C. Wainwright Maintains Telix Pharmaceuticals(TLX.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• Telix Pharmaceuticals Raised to Buy From Hold by Bell Potter TLX.AU
  Dow Jones · 2026/9/15
• H.C. Wainwright Initiates Telix Pharmaceuticals(TLX.US) With Buy Rating, Announces Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• Telix: Mark Nelson Will Continue to Serve on the Bd as a Non-Executive Director, Having Served as Interim Chair TLX.AX.AU
  Dow Jones · 2026/9/1
• William Blair Initiates Telix Pharmaceuticals(TLX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/23

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。